BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Spherics
Spherics focused on applying its oral drug delivery platform to develop products with improved therapeutic profiles.
Spherics
Mansfield, MA
